Show simple item record

dc.contributor.authorSwamy, R.
dc.contributor.authorFrancis, B.A.
dc.contributor.authorAkil, H.
dc.date.accessioned2019-11-20T15:51:42Z
dc.date.available2019-11-20T15:51:42Z
dc.date.issued2019
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074590216&doi=10.1111%2fceo.13639&partnerID=40&md5=fd3a23c5810ae771f348b76e5954ec46
dc.identifier.urihttp://hdl.handle.net/10713/11431
dc.description.abstractImportance: To evaluate the safety and efficacy of ab interno trabeculotomy (AIT) (trabecular ablation) with the trabectome in patients with uveitic glaucoma. Background: Traditional glaucoma filtration surgeries in the uveitic patient population come with a higher risk of complications such as failure and hypotony. Design: Retrospective observational cohort study. Participants: All patients diagnosed with uveitic glaucoma were included in this study. Patients were excluded if they have less than 12 months of follow-up. Methods: All patients who received AIT alone or combined with phacoemulsification. Main Outcome Measures: Major outcomes include intraocular pressure (IOP), number of glaucoma medications and secondary glaucoma surgery, if any. Kaplan-Meier method was used for survival analysis and success was defined as IOP ≤21 mmHg, at least 20% IOP reduction from baseline for any two consecutive visits after 3 months, no additional glaucoma medications, and no secondary glaucoma surgery. Results: A total of 45 eyes, 45 patients, with an average age of 52 years were included in the study. The majority were Japanese (40%) and underwent AIT alone (71%). IOP was reduced from 29.2 ± 8.0 to 16.7 ± 4.6 mmHg at 12 months (P < .01*), while the number of glaucoma medications was reduced from 4.0 ± 1.0 to 2.5 ± 1.6 (P < .01*). Survival rate at 12 months was 91%. Six cases required secondary glaucoma surgery and no other serious complication were reported. Conclusions and Relevance: The trabectome AIT procedure appears to be effective in reducing IOP in uveitic glaucoma patients. Although no statistically significant difference was found in the number of glaucoma medications, a decreasing trend was found. Copyright 2019 The Authors.en_US
dc.description.urihttps://doi.org/10.1111/ceo.13639en_US
dc.language.isoen_USen_US
dc.publisherBlackwell Publishingen_US
dc.relation.ispartofClinical and Experimental Ophthalmology
dc.subjectab interno trabeculotomyen_US
dc.subjectglaucoma treatmenten_US
dc.subjecttrabectomeen_US
dc.subjectuveitisen_US
dc.titleClinical results of ab interno trabeculotomy using the trabectome in patients with uveitic glaucomaen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/ceo.13639
dc.identifier.pmid31505089


This item appears in the following Collection(s)

Show simple item record